Hepatitis C Virus Infection Completed Phase 3 Trials for Asunaprevir (DB11586)

Indication	Status	Phase
DBCOND0033268 (Hepatitis C Virus Infection)	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02123654	UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C	Treatment	Asunaprevir (DB11586) Beclabuvir (DB12225) Daclatasvir (DB09102)
NCT01718145	A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects	Treatment	Asunaprevir (DB11586) Daclatasvir (DB09102) Ribavirin (DB00811) Telaprevir (DB05521)